A carregar...
ADOPTIVE IMMUNOTHERAPY WITH ANTIGEN-SPECIFIC T CELLS EXPRESSING A NATIVE TCR
Although T cells genetically modified with chimeric antigen receptors became the first immune effector product to obtain FDA approval, T-cell products that recognize their antigenic targets through their native receptors have also produced encouraging responses. For instance, T cells recognizing imm...
Na minha lista:
| Publicado no: | Cancer Immunol Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6462216/ https://ncbi.nlm.nih.gov/pubmed/30936089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-18-0888 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|